Cannabinoid-focused biotechnology company Demetrix announced Thursday it secured $50 million in a Series A funding round led by Tuatara Capital. Another investor is Horizons Ventures, which previously ...

With skyrocketing demand for consumer products and renewed research into its medicinal value, cannabis is having a moment. The quasi-legalization of marijuana created a gold rush for the industry, and ...

Researchers at the Berkeley-based startup Demetrix have engineered yeast to produce a variety of cannabinoids using less water, land and energy than traditional farming methods. Co-founded by UC ...

BERKELEY, Calif., Feb. 23, 2021 /PRNewswire/ -- Demetrix, Inc., a biotechnology company that makes safe, legal, and effective cannabinoids, took another major step towards commercialization today, ...

Demetrix has raised $50 million in a first round of venture funding to establish high-volume fermentation production of tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Backers ...

Whether or not you partake in the $30 billion legal cannabis market, the legalization of cannabis in parts of the U.S. and Canada has helped to destigmatize and legalize the use of the cannabinoid ...

Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production ...

EMERYVILLE, Calif., March 4, 2019 /PRNewswire/ -- Demetrix, Inc., a company with world-class expertise in producing nature's ingredients using fermentation, today announced entry into an exclusive ...

It’s 2021 and regular THC isn’t going to cut it for the budding weed industry. Neither will CBD. Instead, a host of startups are betting that weed consumers will be clamoring for something that nature ...

The legalization of cannabis has created many opportunities for researchers to study the compounds in the cannabinoid family and discover new uses for them. Demetrix, a synthetic biology company ...